Pfizer Inc. shares fell after it halted early development of an oral drug for weight loss on safety concerns
and Eli Lilly & Co. in an obesity-treatment market estimated to grow to more than $100 billion in size in the coming years. Pfizer is pinning its hopes on danuglipron, another treatment still in development, to compete with the likes of Novo’s Wegovy and Lilly’s Mounjaro, both seen as blockbuster market leaders.
“A twice-daily pill could prove challenging, assuming all else is equal, leaving Pfizer’s $10 billion peak-sales estimate for danuglipron looking optimistic,” Bloomberg Intelligence analysts John Murphy and Mila Bankovskaia said in a note.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US shale oil and gas producers pull back after commodity price drop\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Read more »
US shale oil and gas producers pull back after commodity price drop\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Read more »
Exact day to take a meter reading as energy prices to drop within daysThe average household will be saving almost £500 a year as the Ofgem energy price cap is reintroduced.
Read more »
Six times Pink made Hyde Park’s jaw drop during outrageous Summer CarnivalPink drenched BST Hyde Park in her glittering, acrobatic sunshine and proved she still knew how to Get The Party Started.
Read more »